Restless legs syndrome: A community-based study of prevalence, severity, and risk factors

Neurology

Volumn 64, Issue 11, 2005, Pages 1920-1924

  Hogl B ^a   Kiechl, S ^a   Willeit, J ^a   Saletu, M ^a   Frauscher, B ^a   Seppi, K ^a   Muller J ^a   Rungger, G ^b   Gasperi, A ^b   Wenning, G ^a   Poewe, Werner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b BRUNECK HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; COMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; LABORATORY TEST; MALE; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RISK FACTOR; TRANSFERRIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DOPAMINE; FEMALE; FERRITINS; HEALTH SURVEYS; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; RESTLESS LEGS SYNDROME; RISK FACTORS; SEX FACTORS; TRANSFERRIN;

EID: 20444372942     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000163996.64461.A3     Document Type: Article

References (32)

1. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000;54:1064-1068.
2. Ulfberg J, Nystrom B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001;46:17-19.
3. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159-1163.
4. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
5. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-743.
6. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196-202.
7. Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001;16:577-579.
8. Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003;61:1562-1569.
9. Oboler SK, Prochazka AV, Meyer TJ. Leg symptoms in outpatient veterans. West J Med 1991;155:256-259.
10. Kushida CA, Nichols DA, Simon RD, et al. Symptom-based prevalence of sleep disorders in an adult primary care population. Sleep Breath 2000;4:9-14.
11. Nichols DA, Allen RP, Grauke JH, et al. Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 2003;163:2323-2329.
12. Trenkwalder C, Wetter TC, Stiasny K, Clarenbach P. Restless legs syndrome and periodic limb movements in sleep. Nervenarzt 2001;72:425-436.
13. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-246.
14. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb 1993;13:661-668.
15. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-3307.
16. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-192.
17. Muller J, Kiechl S, Wenning GK, et al. The prevalence of primary dystonia in the general community. Neurology 2002;59:941-943.
18. Schett G, Kiechl S, Redlich K, et al. Soluble RANKL and risk of non-traumatic fracture. JAMA 2004;291:1108-1113.
19. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
20. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
21. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group Rating Scale for restless legs syndrome. Sleep Med 2003;4:121-132.
22. Baecke JA, Burema HJ, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-942.
23. Kiechl S, Willeit J, Bonora E, Schwarz S, Xu Q. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck study). Arterioscler Thromb Vasc Biol 2000;20:1094-1100.
24. Cook JD. The measurement of serum transferrin receptor. Am J Med Sci 1999;318:269-276.
25. Breslow NE, Day NE. The design and analysis of cohort studies. In: Breslow NE, Day NE, eds, Statistical methods in cancer research. Volume 2. New York: Oxford University Press, 1987.
26. Beckett LA, Scherr PA, Evans DA. Population prevalence estimates from complex samples. J Clin Epidemiol 1992;45:393-402.
27. Hosmer DW, Lemeshow S: Applied logistic regression. New York: John Wiley & Sons, 1988.
28. Berger K, von Eckardstein A, Trenkwalder C, Rothdach A, Junker R, Weiland SK. Iron metabolism and the risk of restless legs syndrome in an elderly general population-the MEMO-Study. J Neurol 2002;249:1195-1199.
29. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-265.
30. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-309.
31. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004;62:1563-1567.
32. Barley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700.